Eaton Vance Management’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-457
Closed -$47K 2675
2021
Q4
$47K Buy
457
+75
+20% +$7.48K ﹤0.01% 2131
2021
Q3
$0 Sell
382
-90
-19% -$8.66K ﹤0.01% 2688
2021
Q2
$48K Buy
472
+422
+844% +$42.4K ﹤0.01% 2170
2021
Q1
$5K Buy
+50
New +$4.55K ﹤0.01% 2622

Other funds holding USNA

Eaton Vance Management's USNA Position: Q1 2022 in Review

Eaton Vance Management sold out of Usana Health Sciences (USNA) in Q1 2022, closing a stake of 457 shares — an estimated $47K sold.

Eaton Vance Management first reported a position in USNA in Q1 2021 and held it in 4 quarters. The position peaked at $48K in Q2 2021. 179 funds tracked by Wall St. Rank hold USNA as of Q1 2022.

  • Eaton Vance Management reported no remaining Usana Health Sciences position as of Q1 2022 after selling out during the quarter.
  • Eaton Vance Management sold 457 Usana Health Sciences shares in Q1 2022, an estimated $47K.
  • Eaton Vance Management first reported a position in Usana Health Sciences in Q1 2021 and held it in 4 quarters.
  • Eaton Vance Management's Usana Health Sciences position peaked at $48K in Q2 2021.
  • 179 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2022.

Based on Eaton Vance Management's 13F filing for Q1 2022, filed 16 May 2022.